NCT00314028 Effectiveness of HIV Risk Reduction Program Among African American Men Status COMPLETED Phase PHASE3
NCT00299091 Modification of Doses of Efavirenz According to Its Blood Concentration in HIV Patients Status COMPLETED Phase PHASE4
NCT00298350 Ritonavir-Boosted GS-9137 vs. Ritonavir-Boosted Protease Inhibitor(s) in Combination With Background ART. Status COMPLETED Phase PHASE2
NCT00295477 Evaluate the Tolerability and Therapeutic Effects of Repeated Doses of Autologous T Cells With VRX496 in HIV Status COMPLETED Phase PHASE1
NCT00286377 Safety and Efficacy Study of Prosaptide to Treat Neuropathic Pain in HIV-Positive Patients Status TERMINATED Phase PHASE2
NCT00271856 Staying Well: A Clinical Trial of Mindfulness-Based Stress Reduction and Education Groups for HIV Status COMPLETED Phase PHASE2
NCT00270556 Phase II Comparator Study of Substitution of Tenofovir or Abacavir Receiving Thymidine Analogue as Part of HAART. Status COMPLETED Phase PHASE2
NCT00270465 Safety and Immune Response to a Prime-Boost Vaccination Schedule in HIV-infected Patients Status COMPLETED Phase PHASE1
NCT00264823 Nursing Intervention for HIV Regime Adherence Among People With Serious Mental Illness (SMI) Status COMPLETED Phase PHASE2
NCT00260767 Imaging Trial of the Distribution of Topical Gel in the Human Vagina: Enhanced MRI Techniques to Increase Resolution Status UNKNOWN Phase PHASE1
NCT00258557 TMC114-C211: Trial of an Investigational Protease Inhibitor TMC114 With Ritonavir ("TMC114/r") in HIV-1 Infected Patients Who Have Never Been Treated With Antiretroviral Medications. Status COMPLETED Phase PHASE3
NCT00255099 TMC125-C216: A Phase III Study to Investigate the Efficacy, Tolerability and Safety of TMC125 as Part of an Antiretroviral Regimen, Including TMC114/Ritonavir and an Investigator-selected Optimized Background, in HIV-1 Infected Patients With Limited to no Treatment Options. Status COMPLETED Phase PHASE3
NCT00254046 TMC125-C206: A Phase III Study to Investigate the Efficacy, Tolerability and Safety of TMC125 as Part of an Antiretroviral Regimen, Including TMC114/Ritonavir and an Investigator-selected Optimized Background, in HIV-1 Infected Patients With Limited to no Treatment Options. Status COMPLETED Phase PHASE3
NCT00250549 A Theory Based HIV Prevention Video For Rapid HIV Testing: A Randomized Trial Status COMPLETED Phase NA
NCT00247143 High Dose Ritonavir/Lopinavir Liquid Formulation in Salvage Therapy for Protease Inhibitor Resistant HIV Disease Status UNKNOWN Phase NA